What Is DHT? The Complete Guide to Dihydrotestosterone and Hair Loss

Dihydrotestosterone (DHT) is the single most important hormone in male pattern baldness. If you're experiencing hair loss — or want to prevent it — understanding DHT is the first step.

This guide covers exactly what DHT is, how it causes follicles to shrink, who's at risk, and what the clinical evidence says about blocking it.

What Is DHT?

DHT (dihydrotestosterone) is an androgen — a hormone that contributes to the development of male physical characteristics. It's derived from testosterone through the action of an enzyme called 5-alpha reductase (5-AR).

Here's the key fact: DHT is significantly more potent than testosterone. It has approximately double the binding affinity to androgen receptors and a dissociation rate about five times slower than testosterone. In other words, DHT sticks around longer and hits harder.

How DHT Is Produced

About 10% of circulating testosterone is converted to DHT by 5-alpha reductase in peripheral tissues — primarily the scalp, skin, and prostate. The enzyme exists in two main forms:

• Type I 5-AR — found in sebaceous glands, epidermis, and hair follicles
• Type II 5-AR — found in the dermal papilla of hair follicles, prostate, and liver

Type II is the most biologically relevant isoenzyme for hair loss and accounts for approximately 80% of circulating DHT.

DHT Levels in the Body

Circulating DHT levels are typically about 10% of circulating testosterone levels. However, because DHT is produced locally in peripheral tissues, tissue concentrations can be up to 10 times greater than what's measured in blood tests. This is why blood tests for DHT don't always correlate with the degree of hair loss — the real action is happening at the follicle level.

How DHT Causes Hair Loss

The mechanism is well-established in dermatological research:

Step 1: DHT Binds to Androgen Receptors

Hair follicles on the scalp contain androgen receptors (ARs) in the dermal papilla cells. These receptors are proteins that allow hormones like DHT to bind and trigger biological responses. The androgen receptor gene sits on the X chromosome — which is why male pattern baldness has historically been linked to maternal inheritance — though we now know both parents contribute through over 600 genetic variants.

Step 2: Follicular Miniaturization

Once DHT binds to the androgen receptor in the dermal papilla, it initiates a cascade of events:

1. Shortening of the anagen (growth) phase — The growth cycle becomes progressively shorter with each cycle
2. Reduction in dermal papilla size — The signaling center of the follicle shrinks
3. Transformation from terminal to vellus hair — Thick, pigmented hairs are replaced by fine, colorless hairs
4. Eventual follicle atrophy — The follicle may stop producing visible hair entirely

This process is called follicular miniaturization and is the histological hallmark of androgenetic alopecia (AGA).

Step 3: The DHT-PGD2 Loop

Recent research (2025) has revealed a vicious cycle that accelerates hair loss:

• Elevated DHT promotes increased Prostaglandin D2 (PGD2) production
• PGD2 reciprocally enhances testosterone formation in keratinocytes
• Both DHT and PGD2 suppress Wnt/β-catenin signaling — the core pathway for hair growth
• The protein CXXC5 appears to be the downstream mediator of this loop

This DHT-PGD2 cycle explains why hair loss accelerates over time rather than remaining constant.

Which Follicles Are Affected?

Not all hair follicles are equally sensitive to DHT. The scalp has distinct zones:

• Highly sensitive: Vertex (crown), temples, mid-frontal scalp
• Resistant: Occipital (back of head), temporal sides

This is why male pattern baldness follows a predictable pattern — and why occipital hairs can be transplanted successfully: they're androgen-resistant and retain their characteristics even when moved to balding areas.

Who Is at Risk?

Genetics

Androgenetic alopecia is a polygenic trait — influenced by hundreds of genes rather than a single one. While the androgen receptor gene on the X chromosome plays a significant role, genome-wide association studies have identified over 600 genetic risk variants across multiple chromosomes.

Key findings from research:

• Sons have a 5-6 times higher risk if their fathers experienced balding
• Both maternal and paternal genes contribute to risk
• Having a genetic predisposition doesn't guarantee severe hair loss — environmental and lifestyle factors also matter

Age

DHT-related hair loss typically begins after puberty and progresses with age:

• By age 30: approximately 25% of men show some degree of recession
• By age 50: approximately 50% of men are affected
• By age 70: approximately 80% of men show significant thinning

Other Risk Factors

Research from a 2026 meta-analysis identified several factors associated with AGA progression:

• Smoking (OR 1.60) — impairs follicular blood flow and increases oxidative stress
• Alcohol consumption (OR 1.72) — linked to progression, possibly through metabolic syndrome
• Insufficient sleep (OR 1.36) — disrupts hormonal balance
• Overweight/obesity (OR 2.31) — promotes progression through metabolic dysfunction
• Insulin resistance — increases 5-alpha reductase activity, producing more DHT
• Hypertension in men (OR 1.60) — correlated with AGA presence

How Is DHT Measured?

While serum DHT levels can be measured through blood tests, their clinical utility in diagnosing AGA is debated. Studies show no statistical significance or correlation between serum DHT levels and the progression of baldness. This is because:

1. Most DHT action occurs at the tissue level, not in circulation
2. Individual sensitivity to DHT varies based on androgen receptor density and genetics
3. Scalp DHT levels are difficult to measure non-invasively

The diagnosis of AGA is typically made clinically — based on pattern recognition, family history, and physical examination — rather than through hormone testing.

Treatments That Target DHT

FDA-Approved DHT Blockers

Finasteride (Propecia)

• Inhibits Type II 5-alpha reductase
• Reduces scalp DHT by approximately 64% and serum DHT by 68% at 1mg daily
• In clinical trials, approximately 99% of participants showed either decreased or reversed hair loss
• Effects are visible after 6 months, peak at 12-15 months
• Requires continuous use — all effects are lost upon discontinuation

Dutasteride (Avodart)

• Inhibits both Type I and Type II 5-alpha reductase
• More potent than finasteride — may be superior for younger males
• Not FDA-approved specifically for hair loss (used off-label)
• Associated with higher rates of sexual side effects than finasteride

Topical DHT Blockers

Topical Finasteride (0.25%)

• Applied directly to the scalp
• Achieves similar local DHT reduction with significantly less systemic impact
• Studies show comparable hair regrowth to oral finasteride
• Reduces risk of systemic side effects

Clascoterone (Cortexolone 17α-propionate)

• First-in-class topical androgen receptor antagonist
• Competes with DHT binding sites on androgen receptors
• FDA-approved for acne; currently in clinical trials for AGA
• Represents the first new mechanism of action in hair loss treatment in 30 years

Non-DHT Medical Treatments

While not DHT-specific, these treatments work through complementary mechanisms:

• Minoxidil — Vasodilator that enhances follicular blood supply and stimulates PGE2 production
• Low-Level Laser Therapy (LLLT) — Stimulates cellular metabolism in follicles
• PRP (Platelet-Rich Plasma) — Growth factors that support follicle health

Natural DHT Modulators

Evidence is limited but emerging for:

• Pumpkin seed oil — Shown to promote hair growth in animal studies
• Saw palmetto (Serenoa repens) — Competitive non-selective inhibitor of androgen receptors
• Caffeine — May prevent hair loss by extending the growth phase and promoting keratin production

The Bottom Line

DHT is the primary hormonal driver of male pattern baldness. It's produced when 5-alpha reductase converts testosterone, and it binds to androgen receptors in genetically susceptible hair follicles, triggering progressive miniaturization.

The good news: effective treatments exist. Finasteride and minoxidil remain the gold standard, with topical alternatives and emerging therapies offering options for those concerned about side effects.

If you're experiencing hair loss, the earlier you act, the more follicles you can preserve. Once the arrector pili muscle detaches from a miniaturized follicle and the follicle atrophies, hair loss is likely irreversible.

Always consult with a qualified healthcare provider before starting any treatment regimen.